Spain Platelet Rich Plasma (prp) Market Size & Outlook
Spain platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
Spain platelet rich plasma (prp) market highlights
- The Spain platelet rich plasma (prp) market generated a revenue of USD 16.7 million in 2023 and is expected to reach USD 45.1 million by 2030.
- The Spain market is expected to grow at a CAGR of 15.3% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 16.7 million |
| Market revenue in 2030 | USD 45.1 million |
| Growth rate | 15.3% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Spain accounted for 2.6% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 123.0 million by 2030.
Pure prp was the largest segment with a revenue share of 51.5% in 2023. Horizon Databook has segmented the Spain platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
Recent strides in cell biology and engineering, bolstered by fresh insights from diverse scientific domains, enable innovative therapeutic approaches in regenerative medicine. Spain is witnessing a noteworthy trend as PRP therapies gain prominence across a multitude of medical disciplines, including dentistry, dermatology, traumatology, and the more recent application in ophthalmology.
These trends reflect the evolving landscape of regenerative medicine in Spain, with PRP therapies playing a pivotal role in advancing patient care and treatment options.
The introduction of platelet-derived preparations marked a significant milestone in addressing chronic leg ulcers, including the development of the Platelet-derived Wound Healing Formula (PDWHF) for clinical application. This product involved covering ulcerated lesions with collagen embedded in platelet proteins. PDWHF can induce vascularized connective tissue formation within these chronic leg ulcers.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
Spain Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
